tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRTA Stock Latest News

Prothena Board Member Paula Cobb Resigns
Company AnnouncementsProthena Board Member Paula Cobb Resigns
1d ago
8K
PRTA
Prothena price target raised to $19 from $11 at Citizens JMP
PremiumThe Fly
Prothena price target raised to $19 from $11 at Citizens JMP
13d ago
PRTA
Prothena price target raised to $8 from $4 at BofA
PremiumThe Fly
Prothena price target raised to $8 from $4 at BofA
19d ago
NVO
CHRO
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
PremiumRatings
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
20d ago
PRTA
Promising Outlook for Prothena: Buy Rating Backed by Innovative CYTOPE Platform Advancements
PremiumRatings
Promising Outlook for Prothena: Buy Rating Backed by Innovative CYTOPE Platform Advancements
23d ago
PRTA
Prothena Shareholders Approve Capital Reduction Proposal
PremiumCompany AnnouncementsProthena Shareholders Approve Capital Reduction Proposal
24d ago
8K
PRTA
Prothena announces poster presentation on TDP-43 CYTOPE program
Premium
The Fly
Prothena announces poster presentation on TDP-43 CYTOPE program
24d ago
PRTA
Prothena’s Coramitug: Promising Phase 2 Results and Buy Rating for ATTR-CM Advancements
Premium
Ratings
Prothena’s Coramitug: Promising Phase 2 Results and Buy Rating for ATTR-CM Advancements
1M ago
PRTA
Prothena highlights positive Phase 2 Coramitug data published in AHA journal
PremiumThe Fly
Prothena highlights positive Phase 2 Coramitug data published in AHA journal
1M ago
NVO
PRTA
Prothena price target raised to $30 from $20 at H.C. Wainwright
PremiumThe Fly
Prothena price target raised to $30 from $20 at H.C. Wainwright
1M ago
PRTA
Prothena Corporation’s Q3 2025 Financial and Clinical Updates
PremiumCompany Announcements
Prothena Corporation’s Q3 2025 Financial and Clinical Updates
1M ago
PRTA
Prothena reports Q3 EPS (68c), consensus (54c)
PremiumThe Fly
Prothena reports Q3 EPS (68c), consensus (54c)
1M ago
PRTA
Prothena price target raised to $36 from $15 at Piper Sandler
PremiumThe FlyProthena price target raised to $36 from $15 at Piper Sandler
2M ago
PRTA
Prothena Corporation (PRTA) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Prothena Corporation (PRTA) Q3 Earnings Cheat Sheet
2M ago
PRTA
Prothena price target raised to $20 from $14 at H.C. Wainwright
Premium
The Fly
Prothena price target raised to $20 from $14 at H.C. Wainwright
2M ago
PRTA
Prothena says partner Bristol Myers Squibb’ BMS-986446 granted FDA fast-track
PremiumThe Fly
Prothena says partner Bristol Myers Squibb’ BMS-986446 granted FDA fast-track
2M ago
BMY
PRTA
Prothena price target lowered to $11 from $29 at Citizens JMP
PremiumThe Fly
Prothena price target lowered to $11 from $29 at Citizens JMP
3M ago
PRTA
Prothena price target lowered to $15 from $81 at Piper Sandler
PremiumThe Fly
Prothena price target lowered to $15 from $81 at Piper Sandler
4M ago
PRTA
Prothena Announces Promising Phase 1 Results for PRX012
PremiumCompany Announcements
Prothena Announces Promising Phase 1 Results for PRX012
4M ago
8K
PRTA
Prothena announces Novo Nordisk to advance coramitug into Phase 3
PremiumThe FlyProthena announces Novo Nordisk to advance coramitug into Phase 3
4M ago
NVO
PRTA
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk
Premium
Company Announcements
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk
4M ago
8K
PRTA
Prothena’s Strategic Initiatives and Promising Alzheimer’s Pipeline Drive Buy Rating
Premium
Ratings
Prothena’s Strategic Initiatives and Promising Alzheimer’s Pipeline Drive Buy Rating
4M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >